Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2012
10/24/2012EP2513096A1 Substituted aminothiazolone indazoles as estrogen related receptor-a modulators
10/24/2012EP2513089A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
10/24/2012EP2513083A1 Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2513071A1 Thiazole derivatives for treating diseases such as cancer
10/24/2012EP2513057A1 Sphingosine kinase inhibitors
10/24/2012EP2513051A1 Combretastatin derivatives and uses therefor
10/24/2012EP2512601A2 Cancer diagnosis and treatment
10/24/2012EP2512522A2 Particles for multiple agent delivery
10/24/2012EP2512521A2 Dendritic high-molecular-weight polymer drug carriers and their conjugates with drugs especially for treatment of solid tumours
10/24/2012EP2512510A1 A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy
10/24/2012EP2512502A2 Methods and compositions for liquidation of tumors
10/24/2012EP2512499A1 Use of a neurofilament peptide for the treatment of glioma
10/24/2012EP2512497A1 Methods and compositions related to clot-binding compounds
10/24/2012EP2512485A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance
10/24/2012EP2512476A1 Method for treating haematological cancers
10/24/2012EP2512473A1 Tumour treatment agents and method
10/24/2012EP2512469A1 3-(indolyl)-or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarzinoma
10/24/2012EP2512468A1 METHOD OF TREATING SCARS AND ß-CATENIN-MEDIATED DISORDERS USING NEFOPAM COMPOUNDS
10/24/2012EP2512250A1 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/24/2012CN102753579A Anti-cadherin antibody
10/24/2012CN102753567A Mybl2 peptides and vaccines containing the same
10/24/2012CN102753564A 6-substituted estradiol derivatives and methods of use
10/24/2012CN102753559A Conjugates of pyrrolo[1,4]benzodiazepine dimers as anticancer agents
10/24/2012CN102753557A Salt of fused heterocyclic derivative and crystal thereof
10/24/2012CN102753554A Raf inhibitor compounds and methods of use thereof
10/24/2012CN102753553A 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8H-purin-8-one maleate
10/24/2012CN102753549A Compounds and methods for kinase modulation, and indications therefor
10/24/2012CN102753548A Fused heteroaromatic pyrrolidinones
10/24/2012CN102753547A 三唑并吡啶衍生物 Triazole and pyridine derivatives
10/24/2012CN102753546A A novel 5-membered heterocycle derivatives and manufacturing process thereo
10/24/2012CN102753542A Substituted benzoazepines as toll-like receptor modulators
10/24/2012CN102753538A Sultam derivatives
10/24/2012CN102753522A Substituted pyrrolidine-2-carboxamides
10/24/2012CN102753193A Light targeting molecules and uses thereof
10/24/2012CN102753191A Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination
10/24/2012CN102753188A Methods for treating brain tumors
10/24/2012CN102753176A Therapeutic combination comprising a cdc7 inhibitor and an antineoplastic agent
10/24/2012CN102753169A Topical transdermal dexmedetomidine compositions and methods of use thereof
10/24/2012CN102753168A Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
10/24/2012CN102753164A Cancer stem cell-targeted and drug resistant cancer therapy
10/24/2012CN102753162A Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
10/24/2012CN102750459A Anti-HPV (human papillomavirus) medicine virtual screening method by using DNA helicase E1 of HPV as target point
10/24/2012CN102747096A Gene search vector, random gene mutation control method and application thereof
10/24/2012CN102747083A Application of splicing factor oncoprotein SF2/ASF in preparation of medicines used for treating leukemia
10/24/2012CN102747047A Human papillomaviruse type hybrid virus-like particles and preparation method thereof
10/24/2012CN102747046A Construction method and application of oncolytic adenovirus targeting CD123 positive leukemia cell
10/24/2012CN102747039A Tumor-associated antigen, monoclonal antibody and purpose thereof
10/24/2012CN102746995A Preparation method for isochromophilone VIII and application of same in preparation of antineoplastic drugs
10/24/2012CN102746973A Formula and preparation method of health-preserving kidney-tonifying wine
10/24/2012CN102746474A Preparation method of temperature and pH sensitive shell cross-linked polymeric micelle
10/24/2012CN102746418A Sansevieria trifasciata polysaccharides as well as preparation method and application thereof
10/24/2012CN102746402A Fully-humanized anti-human prolactin receptor single-chain antibody and application thereof
10/24/2012CN102746401A Polypeptide compound for inhibiting angiogenesis and tumor growth
10/24/2012CN102746400A Antibodies against human angiopoietin 2
10/24/2012CN102746399A Anti-Ngf Antibodies And Methods Using Same
10/24/2012CN102746386A Polypeptide for preventing and treating cell proliferative disorders
10/24/2012CN102746380A Application of angiogenesis inhibitor polypeptide to preparation of medicine for treating tumor and rheumatoid arthritis
10/24/2012CN102746378A Anti-fatty acid synthetase polypeptide and its application
10/24/2012CN102746375A Preparation method of soybean lactoalbumin with antitumor function
10/24/2012CN102746360A Synthesis and application of four new conjugates of camptothecin-steroid
10/24/2012CN102746336A Phosphoramidate alkylator prodrugs
10/24/2012CN102746316A An m-nitroarylmethoxy camptothecin anoxic activation prodrug for antitumor drugs
10/24/2012CN102746314A Stable 7-membered lactonic ring-containing camptothecin compound and its preparation method and use
10/24/2012CN102746309A 1-N-ethyl-4-N-2'-substituted acylhydrazine-1H-pyrazol [3, 4-d] miazines derivative as well as preparation method and application thereof
10/24/2012CN102746308A Allopurinol derivative and preparation method and application thereof
10/24/2012CN102746307A 1-N-benzyl allopurinol derivative as well as preparation method and application thereof
10/24/2012CN102746306A Allopurinol derivative and preparation method and application thereof
10/24/2012CN102746304A Purinamine compound and preparation method thereof
10/24/2012CN102746302A 1-substituted-3-benzyl-3, 6-diazabicyclo[3, 3, 1]nonane derivatives and preparation method
10/24/2012CN102746301A 8-phenyl-7,8-dihydropyrido[2,3-d]pyrimidin-7-ones and their use as pharmaceuticals
10/24/2012CN102746300A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament
10/24/2012CN102746299A 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
10/24/2012CN102746298A Pyridopyrimidinone inhibitors of Pl3K[alpha]
10/24/2012CN102746292A Cyclized berberine derivatives, preparation method and uses thereof
10/24/2012CN102746285A Compounds and compositions as HEDGEHOG pathway modulators
10/24/2012CN102746281A 4-1,2,3-triazole-coumarin derivative and its preparation method and application
10/24/2012CN102746278A Chiral pseudonucleoside compound and its preparation method and use
10/24/2012CN102746258A Crystal forms of cabazitaxel and preparation method thereof
10/24/2012CN102746255A Compound having anti-tumor activity, and preparation method and application thereof
10/24/2012CN102746241A 2, 3, 5-trisubstituted benzamide compound, and preparation method and application thereof
10/24/2012CN102746226A Acridine derivative and preparation method and application thereof
10/24/2012CN102746213A Cinnamamide histone deacetylase inhibitor, preparation method thereof, and application thereof
10/24/2012CN102746212A Beta-elemene indole derivative, preparation and application thereof
10/24/2012CN102746173A Emodin derivative and preparation method and application thereof
10/24/2012CN102746160A Cinnamic acid derivative crystal and preparation method thereof
10/24/2012CN102743766A Cancer suppressor gene-based anti-liver cancer preparation and preparation process thereof
10/24/2012CN102743765A Application of miR-10a gene in non-small cell lung cancer
10/24/2012CN102743762A Receptor-mediated quantum dot tracing targeted drug delivery system, preparation method thereof and application
10/24/2012CN102743761A System purification, detection and treatment
10/24/2012CN102743759A Phosphatase-regulated supramolecular nanosphere and preparation method thereof
10/24/2012CN102743753A Preparation method of rare earth-modified oxygen-carrying carbon nanotube
10/24/2012CN102743752A Composite nano-particles used in inorganic photodynamic therapy, and preparation method thereof
10/24/2012CN102743745A Controlled-release hepatoma cell vaccine depending on granulocyte-macrophage colony-stimulating factor (GM-CSF) wrapped by nanoparticles
10/24/2012CN102743710A Anti-cancer and hemostatic Chinese patent drug
10/24/2012CN102743685A Oldenlandia anti-cancer pills
10/24/2012CN102743684A Pure traditional Chinese medicine for treating leukemia
10/24/2012CN102743598A var. Denneanum extract and formula particles thereof
10/24/2012CN102743563A Anticancer beverage
10/24/2012CN102743548A Application of airpotato yam rhizome in preparation of medicaments for treating thyroid and tincture
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 2211